RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260375

FDA DEVICE FACTS

Nd: YAG Laser Therapy Systems

Sanhe Meditech Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 31, 2026PRODUCT CODEGEXCLINICAL AREASurgery

Indications for use

The Nd:YAG Laser Therapy Systems are intended for tattoo removal; treatment of benign vascular lesions; treatment of benign pigmented lesions; and incision, excision, ablation, and vaporization of soft tissue for general dermatology, as follows: 532 nm wavelength:

- Removal of light-ink tattoos (red, sky blue, green, purple, and orange).

- Treatment of benign vascular lesions including, but not limited to, telangiectasias.

- Treatment of benign epidermal pigmented lesions including, but not limited to, café-au-lait spots, solar lentigines, senile lentigines, Becker's nevi, freckles, nevus spilus, and seborrheic keratoses.

- Treatment of post-inflammatory hyperpigmentation. 1064 nm wavelength:

- Removal of dark-ink tattoos (black, blue, and brown).

- Removal of benign dermal pigmented lesions including, but not limited to, nevus of Ota, common nevi, and melasma.

- Removal or lightening of unwanted hair with or without adjuvant preparation.

- Skin resurfacing procedures for treatment of acne scars and wrinkles.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026